Literature DB >> 8015967

Leucine-enkephalin metabolism in brain microvessel endothelial cells.

S E Thompson1, K L Audus.   

Abstract

The metabolism of leucine-enkephalin was investigated in primary cultures of bovine brain microvessel endothelial cell (BMEC) monolayers. Leucine-enkephalin was hydrolyzed slowly with less than 40% of the peptide metabolized following a 5-h incubation with intact BMEC monolayers at 37 degrees C. Following separation and extraction of BMEC enzymes into cytosolic and membrane-bound fractions, leucine-enkephalin was observed to be labile in the presence of both cytosolic and membrane-associated enzymes. A much greater concentration of enkephalin-hydrolyzing enzyme was associated with the cytosolic fraction. Resulting metabolite profiles for leucine-enkephalin appeared to be the result of interactions of the peptide with primarily aminopeptidases and angiotensin-converting enzyme. Our results suggested that extensive metabolism of leucine-enkephalin solely by BMECs in the cerebro-vasculature would require internalization by the cells and presentation to cytosolic enzymes.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8015967     DOI: 10.1016/0196-9781(94)90178-3

Source DB:  PubMed          Journal:  Peptides        ISSN: 0196-9781            Impact factor:   3.750


  7 in total

1.  Investigation of the metabolism of substance P at the blood-brain barrier using LC-MS/MS.

Authors:  Arvind K Chappa; Joshua D Cooper; Kenneth L Audus; Susan M Lunte
Journal:  J Pharm Biomed Anal       Date:  2006-11-21       Impact factor: 3.935

Review 2.  Analytical and biological methods for probing the blood-brain barrier.

Authors:  Courtney D Kuhnline Sloan; Pradyot Nandi; Thomas H Linz; Jane V Aldrich; Kenneth L Audus; Susan M Lunte
Journal:  Annu Rev Anal Chem (Palo Alto Calif)       Date:  2012       Impact factor: 10.745

Review 3.  Amide Bond Bioisosteres: Strategies, Synthesis, and Successes.

Authors:  Shikha Kumari; Angelica V Carmona; Amit K Tiwari; Paul C Trippier
Journal:  J Med Chem       Date:  2020-08-04       Impact factor: 7.446

4.  Synthesis and Opioid Activity of Tyr1 -ψ[(Z)CF=CH]-Gly2 and Tyr1 -ψ[(S)/(R)-CF3 CH-NH]-Gly2 Leu-enkephalin Fluorinated Peptidomimetics.

Authors:  Somnath Narayan Karad; Mohan Pal; Rachel S Crowley; Thomas E Prisinzano; Ryan A Altman
Journal:  ChemMedChem       Date:  2017-04-05       Impact factor: 3.466

5.  Synthesis of Leu-Enkephalin Peptidomimetics Containing Trifluoromethylalkenes as Amide Isopolar Mimics.

Authors:  Venkateswararao Eeda; Manikandan Selvaraju; Ryan A Altman
Journal:  J Fluor Chem       Date:  2018-12-11       Impact factor: 2.050

6.  Tyr1-ψ[( Z)CF═CH]-Gly2 Fluorinated Peptidomimetic Improves Distribution and Metabolism Properties of Leu-Enkephalin.

Authors:  Ryan A Altman; Krishna K Sharma; Lian G Rajewski; Paul C Toren; Michael J Baltezor; Mohan Pal; Somnath N Karad
Journal:  ACS Chem Neurosci       Date:  2018-04-19       Impact factor: 4.418

7.  The Meta-Position of Phe4 in Leu-Enkephalin Regulates Potency, Selectivity, Functional Activity, and Signaling Bias at the Delta and Mu Opioid Receptors.

Authors:  Robert J Cassell; Krishna K Sharma; Hongyu Su; Benjamin R Cummins; Haoyue Cui; Kendall L Mores; Arryn T Blaine; Ryan A Altman; Richard M van Rijn
Journal:  Molecules       Date:  2019-12-12       Impact factor: 4.411

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.